|Life Extension Update Exclusive |
Cancer-inflammation link found
UCSD professor of pharmacology, Michael Karin PhD, and colleagues discovered that the proinflammatory gene I-kappa-B kinase (IKK beta), acts differently in two cell types to initiate cancer, and that deletion of the gene in mice decreased the incidence of cancer as well as tumor growth. IKK beta is necessary for the activation of nuclear factor kappa B (NF-kB), a protein that promotes cancer in epithelial cells by inhibiting apoptosis. In myeloid cells, the protein induces the expression of proinflammatory molecules that increase tumor size by stimulating cell division. Nuclear factor kappa B also turns on inflammation in bacterial and viral infections.
In a mouse model of colitis associated cancer (a cancer associate with recurrent inflammation) the research team tested the effects of administering a carcinogen and a proinflammatory substance on mice bred to lack IKK beta in their intestinal epithelial cells and in mice lacking the gene in their myeloid cells. (Myeloid cells are involved in immune function.) Although the compounds induced inflammation followed by the development of tumors when given to normal mice, animals lacking IKK beta in their intestinal epithelial cells experienced an 80 percent reduction in tumor formation compared to the normal group, despite the initiation of inflammation. It was found that apoptosis, or programmed cell suicide, was responsible for this reduction. In the mice lacking IKK beta in their myeloid cells, tumor incidence was reduced by one half, and tumors were one-fourth the size of tumors in the normal mice. In this group, apoptosis was not increased, but rather there was a decrease in the expression of pro-inflammatory molecules such as cyclooxygenase and interleukins 1 and 6.
Dr Karin commented, “We've shown how tumors arise from chronic infection and inflammation that act together with chemical carcinogens. In response to chronic infection, the interplay between immune cells and the epithelial cells of the intestinal tract, which become genetically transformed to give rise to malignant cells by the carcinogen, results in increased tumor growth and suppression of apoptosis, whose role is to reduce cancer incidence. Our studies show how NF-kB acts very early in the carcinogenesis process, in two different ways."
For those who have multiple degenerative diseases, the cytokine profile blood test and the C-reactive protein blood test are highly recommended. This may be done through your own physician or the Life Extension Foundation. If your cytokine test reveals excess levels of cytokines such as TNF-a, IL-1(b), or both, nutritional supplementation, dietary modifications, and low-cost prescription medications such as PTX are advised.
The following supplements are suggested:
The docosahexaenoic acid (DHA) fraction of fish oil may be the most effective nonprescription supplement to suppress pro-inflammatory cytokines. Gamma-linolenic acid (GLA) is a precursor of PGE1, a potent anti-inflammatory agent. A product called Super GLA/DHA provides 920 mg of GLA, 1000 mg of DHA, and 400 mg of EPA in 6 capsules.
DHEA is a hormone that decreases with age. DHEA has been shown to suppress IL-6, an inflammatory cytokine that often increases as people age. Typical doses of DHEA are 25-50 mg daily, although some people take 100 mg daily. Refer to the DHEA Replacement protocol for suggested blood tests to safely and optimally use DHEA.
Nettle leaf has been shown to suppress the pro-inflammatory cytokine TNF-a. Take 1000 mg daily.
Vitamin E and N-acetyl-cysteine (NAC) are protective antioxidants with anti-inflammatory properties. Vitamin E that contains gamma-tocopherol and tocotrienols provides the most broad-spectrum protection. Take 1-2 capsules daily of Gamma E Tocopherols/Tocotrienols. NAC is an amino acid with antiviral and liver protectant properties. One 600 mg capsule daily is recommended.
Vitamin K helps reduce levels of IL-6, a pro-inflammatory messenger. Vitamin K also helps in the treatment of osteoporosis by regulating calcium and promoting bone calcification. One 10-mg capsule daily is recommended for prevention purposes. Do not take vitamin K if you are taking Coumadin or some other type of anticoagulant medicine.
Consuming at least 1000 mg a per day of carnosine and/or 300 mg of the European drug aminoguanidine can inhibit pathological glycation reactions in the body.
Supplementation with the right proportions of fatty acids can maximize the production of anti-inflammatory prostaglandins (E1 and E3), while suppressing pro-inflammatory prostaglandin E2 and leukotriene B4. In addition to avoiding saturated fats and high glycemic foods that contribute to chronic inflammation, eating omega-3 foods, and consuming supplements that provide GLA, DHA, and EPA can help control inflammation by bringing balance to the essential fatty acids.
The essential fatty acids in Super GLA/DHA have been concentrated and standardized in order to ensure quality, potency, and biological activity.
One or more members of the vitamin E family may:
Life Extension Daily News is a front page feature of Life Extension’s website that includes news clippings from around the world on the subjects of aging, disease, nutrition and vitamins. New articles are now posted seven days a week to keep you up to date on the latest information as it is published. Visit www.lef.org each day to find out what is happening as it happens in the rapidly advancing world of health and longevity.
Questions? Comments? Send them to firstname.lastname@example.org or call 954 766 8433 extension 7716.
For longer life,
Sign up for Life Extension Update at http://mycart.lef.org/subscribe.asp
Help spread the good news about living longer and healthier. Forward this email to a friend!
View previous issues of Life Extension Update in the Newsletter Archive.